Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer
Rosemary Millen, Jordane Malaterre, Ryan S Cross, Sandra Carpinteri, Jayesh Desai, Ben Tran, Phillip Darcy, Peter Gibbs, Oliver Sieber, Nikolajs Zeps, Paul Waring, Stephen Fox, Lloyd Pereira, Robert G Ramsay
OncoImmunology | TAYLOR & FRANCIS INC | Published : 2016
Related Projects (1)
RGR is supported by a Fellowship from the National Health and Medical Research Council, Australia.